Utilization Management
Prior Authorization, Step Therapy, and Quantity Limit Policies for CareSource Marketplace Business
Not all medications will be covered on the formulary. Non-formulary medications are subject to the Medical Necessity for Non-Formulary Medications policy. Please consult the formulary to verify coverage.
| Hyperlipidemia - Omega-3 Fatty Acid Products PA Policy De-Identified | Policy |
| Hypertension - Clonidine Patches DQM Policy - Per Days De-Identified | Policy |
| Hypoactive Sexual Desire Disorder - Addyi PA Policy De-Identified | Policy |
| Hypoactive Sexual Desire Disorder - Vyleesi PA Policy De-Identified | Policy |
| Idiopathic Pulmonary Fibrosis and Related Lung Disease - Ofev PA Policy De-Identified | Policy |
| Idiopathic Pulmonary Fibrosis and Related Lung Disease - Pirfenidone PA Policy De-Identified | Policy |
| Idiopathic Pulmonary Fibrosis and Related Lung Disease - Pirfenidone PSM Policy De-Identified | Policy |
| Immune Globulin - Atgam PA Policy De-Identified | Policy |
| Immune Globulin - Intravenous PA Policy De-Identified | Policy |
| Immune Globulin - Subcutaneous PA Policy De-Identified | Policy |
| Immune Globulin – Cytogam PA Policy De-Identified | Policy |
| Immunologicals - Adbry DQM Policy - Per Days De-Identified | Policy |
| Immunologicals - Adbry PA Policy De-Identified | Policy |
| Immunologicals - Anti-Interleukin-5 Agents PSM Policy De-Identified | Policy |
| Immunologicals - Dupixent DQM Policy - Per Days De-Identified | Policy |
| Immunologicals - Dupixent PA Policy De-Identified | Policy |
| Immunologicals - Fasenra DQM Policy - Per Days De-Identified | Policy |
| Immunologicals - Nucala DQM Policy - Per Days De-Identified | Policy |
| Immunologicals - Nucala PA Policy De-Identified | Policy |
| Immunologicals - Tezspire PA Policy De-Identified | Policy |
| Immunologicals - Xolair DQM Policy - Per Days De-Identified | Policy |
| Immunologicals – Cinqair PA Policy De-Identified | Policy |
| Immunologicals – Fasenra PA Policy De-Identified | Policy |
| Immunologicals – Xolair PA Policy De-Identified | Policy |
| Immunosuppressive Agents - Rezurock DQM Policy - Per Rx De-Identified | Policy |
| Immunosuppressive Agents - Rezurock PA Policy De-Identified | Policy |
| Infectious Disease - Antiparasitic Agents DQM Policy - Per Days De-Identified | Policy |
| Infectious Disease - Antiparasitics DQM Policy - Per Days De-Identified | Policy |
| Infectious Disease - Impavido PA Policy De-Identified | Policy |
| Infectious Disease - Ivermectin Tablets PA Policy De-Identified | Policy |
| Infectious Disease - Livtencity DQM Policy - Per Days De-Identified | Policy |
| Infectious Disease - Livtencity PA Policy De-Identified | Policy |
| Infectious Disease - Pretomanid PA Policy De-Identified | Policy |
| Infectious Disease - Prevymis DQM Policy - Per Days De-Identified | Policy |
| Infectious Disease - Pyrimethamine PA Policy De-Identified | Policy |
| Infectious Disease - Sirturo PA Policy De-Identified | Policy |
| Infectious Disease - Vancomycin (Oral) DQM Policy - Per Rx De-Identified | Policy |
| Inflammatory Conditions - Actemra Intravenous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Actemra Subcutaneous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Adalimumab Products DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Adalimumab Products PA Policy De-Identified | Policy |
| Inflammatory Conditions - Arcalyst DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Arcalyst PA Policy De-Identified | Policy |
| Inflammatory Conditions - Cibinqo PA Policy De-Identified | Policy |
| Inflammatory Conditions - Cimzia DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Cimzia PA Policy De-Identified | Policy |
| Inflammatory Conditions - Cosentyx DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Cosentyx PA Policy De-Identified | Policy |
| Inflammatory Conditions - Entyvio Intravenous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Etanercept Products DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Etanercept Products PA Policy De-Identified | Policy |
| Inflammatory Conditions - Ilaris PA Policy De-Identified | Policy |
| Inflammatory Conditions - Ilumya DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Ilumya PA Policy De-Identified | Policy |
| Inflammatory Conditions - Infliximab Products PA Policy De-Identified | Policy |
| Inflammatory Conditions - Kevzara PA Policy De-Identified | Policy |
| Inflammatory Conditions - Kineret DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Kineret PA Policy De-Identified | Policy |
| Inflammatory Conditions - Olumiant DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Olumiant PA Policy De-Identified | Policy |
| Inflammatory Conditions - Orencia Intravenous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Orencia Subcutaneous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Otezla DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Otezla PA Policy De-Identified | Policy |
| Inflammatory Conditions - Rinvoq DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Rinvoq PA Policy De-Identified | Policy |
| Inflammatory Conditions - Siliq DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Siliq PA Policy De-Identified | Policy |
| Inflammatory Conditions - Simponi Aria PA Policy De-Identified | Policy |
| Inflammatory Conditions - Simponi Subcutaneous DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Simponi Subcutaneous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Skyrizi Subcutaneous DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Skyrizi Subcutaneous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Sotyktu PA Policy De-Identified | Policy |
| Inflammatory Conditions - Spevigo PA Policy De-Identified | Policy |
| Inflammatory Conditions - Stelara Intravenous PA Policy De-Identified | Policy |
| Inflammatory Conditions - Stelara Subcutaneous DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Stelara Subcutaneous PA Policy with Dosing De-Identified | Policy |
| Inflammatory Conditions - Taltz DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Taltz PA Policy De-Identified | Policy |
| Inflammatory Conditions - Tremfya DQM Policy - Per Days De-Identified | Policy |
| Inflammatory Conditions - Tremfya PA Policy De-Identified | Policy |
| Inflammatory Conditions - Xeljanz Xeljanz XR PA Policy De-Identified | Policy |
| Inflammatory Conditions PSM Policy De-Identified | Policy |
| Interferon - Actimmune PA Policy De-Identified | Policy |
| Interleukin-1 Blockers for Cryopyrin-Associated Periodic Syndromes PSM Policy De-Identified | Policy |
| Iron Replacement – Feraheme PA Policy De-Identified | Policy |
| Iron Replacement – Ferrlecit PA Policy De-Identified | Policy |
| Iron Replacement – INFeD PA Policy De-Identified | Policy |
| Iron Replacement – Injectafer PA Policy De-Identified | Policy |
| Iron Replacement – Monoferric PA Policy De-Identified | Policy |
| Iron Replacement – Venofer PA Policy De-Identified | Policy |
| Isotretinoin Step Therapy Policy De-Identified | Policy |
| Keveyis PA Policy De-Identified | Policy |
| Lipodystrophy - Egrifta PA Policy De-Identified | Policy |
| Lipodystrophy - Myalept PA Policy De-Identified | Policy |
| Lucemyra PA Policy De-Identified | Policy |
| Lupus - Benlysta Intravenous PA Policy De-Identified | Policy |
| Lupus - Benlysta Subcutaneous DQM Policy - Per Days De-Identified | Policy |
| Lupus - Benlysta Subcutaneous PA Policy De-Identified | Policy |